Sort by
Refine Your Search
-
Listed
-
Employer
- Duke University
- University of Texas at El Paso
- The Ohio State University
- The University of Iowa
- Carnegie Mellon University
- Purdue University
- University of Pittsburgh
- Virginia Tech
- California Institute of Technology
- Johns Hopkins University
- National Renewable Energy Laboratory NREL
- Radix Trading LLC
- Texas A&M AgriLife
- Texas A&M University
- University of Alabama at Birmingham
- University of Denver
- University of Kansas
- University of Maryland
- University of Maryland, Baltimore
- University of Massachusetts Medical School
- University of Miami
- University of North Texas at Dallas
- Wayne State University
- Yeshiva University
- 14 more »
- « less
-
Field
-
$500 million in research annually. Virginia Tech endorses and encourages participation in professional development opportunities and university shared governance . These valuable contributions
-
or worsening structural and clinical features and identify risk factors for decline among severely affected children with CZS. Dr. Kelleher’s research uses telehealth-based methods to assess early development
-
. The Theranostics laboratory studies developing new PET probes for management of advanced malignancies and novel radio-ligand therapies for cancer. We are particularly interested in the preclinical development
-
institutional support, where innovation, curiosity, and collaboration are highly valued. The lab environment fosters intellectual independence while providing strong mentorship and career development
-
for knowledge about the human condition and the development of skills to improve our local and global communities. The broad scope of CAHSS allows our students to gain the knowledge and skills necessary
-
development on 3T Philips scanners, and ideally on 7T Bruker scanners as well, (3) expertise in pulse sequence development on 3T Philips scanner, and (4) at least three years of experience in supporting MRI
-
development center (FFRDC) at Carnegie Mellon University. What you’ll do: Develop state of the art approaches for analyzing robustness of AI systems. Apply these approaches to understanding vulnerabilities in
-
based on advancing the development and application of focused ultrasound for non-invasive neuromodulation, ablation, and brain drug/gene delivery. The successful candidate will be an integral part of
-
May) from the University of Chicago. Michael Rauchman - formerly GETCO's CTO, head of Americas equities, and global head of ForEx. As a hands-on leader, Michael was instrumental in the development
-
detectors recording nuclear collisions. The expected candidate has strong experience in ML/AI to facilitate the development of a framework to search for unknown and not yet discovered transitions in